Blue Horseshoe Stocks: ZYNE, LLNKF Recaps

LiteLink Technologies, Inc. (OTCMKTS:LLNKF)(CSE:LLT) – Update

When we profiled LLNKF in a special report yesterday morning, we mentioned that the stock was ‘dripping with upside potential‘, and we were essentially proven right immediately. The stock traded more volume than the two prior sessions combined (23X the 30-day average) as it ran from a low of .1157 on up to .197, which represented an intraday rise of 70%

LLNKF closed just a couple of ticks below its high of day, at .195, and anytime we see a stock do so, especially with increased volume and buying pressure, we definitely want to be on the lookout for a possible continuation of momentum. We’ll look for this play to register higher highs and higher lows and continue this bullish uptrend.


Zynerba Pharmaceuticals, Inc. ZYNE – Recap

We are going to revisit ZYNE this morning, a stock that we have been tracking since back in December, with a followup at the end of January, as well as another just a couple of weeks ago on April 30th. Throughout that period of time, ZYNE has appreciated by leaps and bounds.

Starting from the low we observed shortly following our December alert, at 2.75, the stock has run all the way up to an impressive new high of 15.98 this week. That marks an overall move of 481% since we’ve been watching this play. Readers who may have only caught the most recent report on April 30th, have still seen a range of 9.57-15.98-  a very respectable upswing of 67%


Fresh Options Ideas:
PINS Weekly $27-25.50 Puts*
DE Weekly $140-138 Puts*

*As always, we urge readers not to trade weekly options on a Friday if they are not advanced-level traders with access to disposable funds.


Extended Watchlist:
ADOM, GSAT, GEVO, OCUL, ACRX

Blue Horseshoe Stocks: TSN Recap & More

Tyson Foods Inc. TSN – Update

We started the week off yesterday by formulating some options ideas for TSN. The company had a mixed earnings call, with a beat on Q3 profits, and a miss on sales. We pointed to the technical setup of the chart as our primary reason for being interested, and as it turns out we called the bottom perfectly.

We came up with a short and longer term set of ideas, and while we may yet come back to the long terms, we are looking at the weekly calls we designated today after some solid performances. Those were the TSN Weekly $58-59.50 Calls, and all but the $58’s produced double-bag gains on the session.

$58.50 Calls – Range: .90-2.25 – Max Gain: 150%
$59 Calls – Range: .80-1.68 – Max Gain: 110%
$59.50 Calls – Range: .75-1.50 – Max Gain: 100%



Fresh Options Ideas

Our success with options over the past several weeks has been so pronounced, we see absolutely no reason to stop now, especially being in the thick of another earnings season. We’ve got another pair of earning related options ideas to bring to the table today.

Etsy, Inc. ETSY Weekly $40-50 Calls
Zillow Group, Inc. Z Weekly $48-49 Calls


Extended Watchlist:
TIS, NPTN, RNG, ACRX, MNK, EKSO, VCEL, TWLO

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.


PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.



AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday. 

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.


Extended Watchlist:
 AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,

Blue Horseshoe Stocks: INFI Review & More

Infinity Pharmaceuticals, Inc. INFI

The stock with the most notable performance from yesterday morning’s watchlist was definitely INFI, which began trending up in the premarket, and continued its climb throughout the entire session.

The stock traded up from a low of 2.44 to 3.75, which works out to an intraday rise of 54% and it came on roughly 38X its monthly average volume. An early pullback from profit taking this morning would be a likely scenario, but if INFI can find support at a higher point than yesterday’s low, from



AcelRx Pharmaceuticals, Inc. ACRX

After the FDA’s rejecion of the company’s ‘Dsuvia” opioid painkiller, ACRX took a monstrous pounding yesterday down to its lowest price in three months.

As you can see on the chart, it fell all the way down to an area of support it had established back in July. We’ll be interested to monitor this play for a bottom, which could come at any time. Moves generated by FDA news, whether positive or negative, tend to be over-exaggerated and are almost always followed by a course correction.


Inotek Pharmaceuticals Corp ITEK

Here we have an example of being extremely ‘early to the party’ as we sometimes say. We alerted on ITEK back in July, after which point it saw a low of .89. It mostly traded sideways throughout the remainder of the summer, but recently began quite an impressive climb.

This morning, the stock hit news highs of 4.15 in premarket trading on news of a proposed merger with a clinical stage gene therapy company. It may have took a few months to realize, but it works out to an increase of 366%

For an added angle going forward, we’ll also signal the ITEK 10/20 $2.50 Calls for possible daytrades and/or swing trades into next week, and the 11/17 $2.50 & $5.00 Calls for a longer term idea.


Extended Watchlist:
SONS, MARK, HSC, DPW, AKS, CLF, RIG, ATNM, MGEN

Blue Horseshoe Stocks: Fresh Options Ideas

Fresh Options Ideas

We’re going to start off the new trading week by identifying a couple of options ideas we’re seeing based on the chart setups of Under Armour Inc. (UAA) and CSX Corp (CSX).

In both cases, the stocks have been on a bit of a backslide, but went on to record bullish sessions on Friday. We’re going to look for confirmed reversals on both of these, and be ready with some options ideas if they can establish more sustained rebounds. On each chart, there are gaps to the upside, which is another thing we look for.

For Under Armour, which is giving off a strong multiple-bottom signal, we’re going to track the UAA 09/01 $17-19 Calls, and for CSX Railroads, we’ll want to look after the CSX 09/01 $51-53 Calls.


ImmunoGen Inc. IMGN

We also want to keep IMGN on our radars as we kick things off this week. We signaled it in Friday’s premarket report and it had a modest yet solid session on the heels of an earnings beat. We saw a low of 6.29, and this morning in early trading the stock has reached a high of 7.41.  While that’s only an 18% rise at the moment, we’ll want to keep an eye peeled for another bullish session.


Extended Watchlist:
ACRX, CDRBQ, DVAX, NVIV, MYO, XXII, NXTD, CYTR,MNGG